Identification and Validation of an Immune-Associated RNA-Binding Proteins Signature to Predict Clinical Outcomes and Therapeutic Responses in Glioma Patients

Ruotong Tian(Shanghai Medical College of Fudan University), Minfeng Shu(Shanghai Medical College of Fudan University), Qian Liu(Shanghai Medical College of Fudan University), Yimin Li
Cancers
April 6, 2021
10.3390/cancers13071730
Cited by 14

Related Papers

Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2‐dependent silencing of SLC7A11
|Journal of Cellular and Molecular Medicine|2021|164
Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells
|Molecular Cancer|2011|139
MiR-135a functions as a selective killer of malignant glioma
|Oncogene|2011|91
A Small-Molecule Triptolide Suppresses Angiogenesis and Invasion of Human Anaplastic Thyroid Carcinoma Cells via Down-Regulation of the Nuclear Factor-κB Pathway
|Molecular Pharmacology|2009|80
Overcoming therapeutic resistance in oncolytic herpes virotherapy by targeting IGF2BP3-induced NETosis in malignant glioma
|Nature Communications|2024|67